Alnylam Pharmaceuticals

Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices
BioPharma Dive
Fri, 08/30/24 - 11:20 am
Alnylam Pharmaceuticals
transthyretin amyloidosis cardiomyopathy
Roche, Alnylam say blood pressure drug succeeds in mid-stage trial
Reuters
Tue, 03/5/24 - 11:07 am
Roche
Alnylam Pharmaceuticals
clinical trials
hypertension
zilebesiran
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
clinical trials
Beam Therapeutics
Moderna Therapeutics
Pfizer
Sanofi
Gilead Sciences
JNJ
Amylx
Roche
Alnylam Pharmaceuticals
Vertex Pharmaceuticals
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit
Fierce Pharma
Tue, 05/30/23 - 09:28 pm
Alnylam Pharmaceuticals
legal
patents
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Alnylam’s Onpattro succeeds in open-label ATTR cardiomyopathy extension
Clinical Trials Arena
Mon, 05/22/23 - 10:11 am
Alnylam Pharmaceuticals
Onpattro
clinical trials
transthyretin amyloidosis with cardiomyopathy
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
Brace for an end-of-year boost to drug approvals
EP Vantage
Fri, 09/2/22 - 12:14 pm
FDA
drug approvals
Alnylam Pharmaceuticals
Apellis Pharmaceuticals
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
Mirati Therapeutics
Moderna Therapeutics
Provention Bio
Roche
TG Therapeutics
Travere Therapeutics
Alnylam Reports Positive Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy
Businesswire
Mon, 08/29/22 - 10:26 am
Alnylam Pharmaceuticals
clinical trials
cemdisiran
Regeneron
IgAN
immunoglobultin A nephropathy
RNAi
11 drugs granted FDA fast track designation in 2022
Beckers Hospital Review
Wed, 08/24/22 - 10:55 pm
FDA
fast track
Agios Pharmaceuticals
CTI BioPharma
Bristol Myers Squibb
Nobel Biocare
BioXcel Therapeutics
Mycovia Pharmaceuticals
Phathom Pharmaceuticals
Mitsubishi Tanabe Pharma
SIGA technologies
Alnylam Pharmaceuticals
3 Biopharmas on Buyout Watch
Motley Fool
Mon, 08/22/22 - 10:39 am
M&A
Axsome Therapeutics
Alnylam Pharmaceuticals
Karuna Therapeutics
Drugmakers leap back into fading heart drug market
Beckers Hospital Review
Thu, 07/28/22 - 06:40 pm
Bristol Myers Squibb
Novartis
Merck
Alnylam Pharmaceuticals
Amgen
hypertension
cholesterol
Alnylam sues Pfizer, Moderna over patent used in mRNA COVID vaccines
Seeking Alpha
Thu, 03/17/22 - 10:14 am
Alnylam Pharmaceuticals
patents
COVID-19
vaccines
Pfizer
Moderna Therapeutics
MRNA
Novartis turns to Alnylam in research deal aimed at liver failure
BioPharma Dive
Thu, 01/6/22 - 10:57 am
Novartis
Alnylam Pharmaceuticals
liver failure
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Alnylam Pharmaceuticals
Bio-Thera Solutions
BioArctic
Biogen
BridgeBio Pharma
Daiichi Sankyo
Eisai
JNJ
Madrigal Pharmaceuticals
Merck
Sutro BioPharma
Tasly Pharmaceutical Group